Editorial: Advanced Strategies for the Recognition, Enrichment, and Detection of Low Abundance Target Bioanalytes
Jian Zhang,Jie Jayne Wu,Li Chen
DOI: https://doi.org/10.3389/fbioe.2022.957878
IF: 5.7
2022-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Biosensors and bioassays provide important analysis capabilities for biological, medical, and environmental applications. Owing to active and creative exploration of emerging materials, devices, and methods, there have been great advances in biosensors and bioassays, making detection more sensitive, rapid, accessible, and intelligent. For biodetection, especially for low abundance, strategies for target recognition, enrichment, and detection are of vital importance. The goal of this Research Topic is to provide a forum sharing recent research and novel ideas on related techniques. We have collected eight papers focused on biosensors for target or event detection: three research articles, two opinion articles, and three reviews. The techniques include microfluidics, electrochemistry, CRISPR, emerging materials, and so on. In terms of research papers, Zhu et al. report a microfluidic device integrated with an electrical impedance spectroscopy (EIS) biosensor to perform in-situ impedance measurement of yeast proliferation in single-cell resolution. Hydraulic shear force is utilized to detach a daughter cell from its mother cell, and time-lapse impedance measurement is performed to monitor the cellular process. The main highlight of this work is a combined sensor achieving in-situ and real-time monitoring of a dynamic event for single-cell reproduction, which uses simple EIS instead of image observation, saving hardware resources for image recording. Meanwhile, the capacity to monitor for longer than several hours still needs to be improved. Salvador et al. present the development of a fluorescent microfluidic device based on an antibody microarray for therapeutic drugmonitoring of acenocoumarol (ACL). A fully integratedmicrofluidic system is realized using a specific antibody for ACL on the glass slide in a microarray chip, with a fluorescent label for target binding. A limit of detection (LOD) of 1.23 nM is achieved in human plasma. As a proof-of-concept point-of-care device, this system is automatic and sensitive, although the exact turnaround time is not mentioned. The selectivity also needs to be demonstrated for situations such as the presence of other molecules similar to ACL existing in the blood. Yuan et al. have developed a one-step electropolymerized biomimetic polypyrrole membranebased electrochemical sensor for selective detection of valproate (VPA). The critical point of this strategy is to fabricate molecularly imprinted polymer (MIP) with simple one-step electropolymerization and employ the MIP/gate effect to realize sensitive concentration-electrical signal response. This sensor has a LOD of 17.48 μM and good selectivity against five drugs in Edited and reviewed by: Guozhen Liu, The Chinese University of Hong Kong, Shenzhen, China